Anders Erik Astrup Dahm

1.7k citations

56 papers · 1.1k indexed · h-index 18

Internal Medicine top 1%
- Venous Thromboembolism Diagnosis and Management 29
Hematology top 2%
- Blood Coagulation and Thrombosis Mechanisms 20
- Hemophilia Treatment and Research 5
Genetics top 5%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 12
- Estrogen and related hormone effects 4
Virology top 10%
Cardiology and Cardiovascular Medicine top 10%
- Atrial Fibrillation Management and Outcomes 7
- Antiplatelet Therapy and Cardiovascular Diseases 4
Epidemiology
- Acute Ischemic Stroke Management 4

Co-authors: Per Morten Sandset Frits R. Rosendaal Astrid van Hylckama Vlieg Rogier M. Bertina Bjørn Bendz Jan Rosing Anne Flem Jacobsen R M Bertina
Cited by: Internal Medicine Hematology Genetics
Journals: SHILAP Revista de lepidopterología (1 paper)Blood (3 papers)PLoS ONE (2 papers)
Partner nations: Norway Netherlands United States

In The Last Decade

Anders Erik Astrup Dahm

53 papers receiving 1.0k citations

Peers

Countries citing papers authored by Anders Erik Astrup Dahm

Since Specialization

Citations

This map shows the geographic impact of Anders Erik Astrup Dahm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Erik Astrup Dahm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Erik Astrup Dahm more than expected).

Fields of papers citing papers by Anders Erik Astrup Dahm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Erik Astrup Dahm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Erik Astrup Dahm. The network helps show where Anders Erik Astrup Dahm may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Anders Erik Astrup Dahm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anders Erik Astrup Dahm Line = papers co-authored together Anders Erik Astrup Dahm links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Ruxolitinib in patients with polycythemia vera resistant and/or intolerant to hydroxyurea: European observational study European Journal Of Haematology ·Alexandre Theocharides,Heinz Gisslinger,Valerio De Stefano,Vincenzo Accurso,Alessandra Iurlo,Timothy Devos,Miklós Egyed,Éric Lippert,Regina García Delgado,Nathan Cantoni,Anders Erik Astrup Dahm,Damianos Sotiropoulos,Erik Houtsma,Aoife Smyth,Amir Iqbal,P. Di Matteo,Mike W. Zuurman,Peter A.W. te Boekhorst	2023	1
2	OC 03.5 Arterial Events in Cancer Patients Treated with Apixaban for Venous Thrombosis Research and Practice in Thrombosis and Haemostasis ·Trine‐Lise Larsen,Marte Svalastoga,Jorunn Brekke,Tone Enden,Hege Frøen,Herish Garresori,E Jacobsen,Peter Kildeberg Paulsen,Alina Carmen Porojnicu,Anne Hansen Ree,Dag Torfoss,Elin Ose Velle,H. SkuterudWik,Waleed Ghanima,Per Morten Sandset,Anders Erik Astrup Dahm	2023	1
3	Low Diagnostic Accuracy and Inter-Observer Agreement on CT and MRI in Diagnosis of Spinal Fractures in Multiple Myeloma Hematology Reports ·Viktor Dalen,Anne-Sofie Vegsgaard Olsen,Claude-Pierre Jerome,Jonn Terje Geitung,Anders Erik Astrup Dahm	2021	2
4	Venous thrombosis with oral postmenopausal hormone therapy: Roles of activated protein C resistance and tissue factor pathway inhibitor Journal of Thrombosis and Haemostasis ·Deeksha Khialani,Sowmya Vasan,Mary Cushman,Anders Erik Astrup Dahm,Per Morten Sandset,Jacques E. Rossouw,Astrid van Hylckama Vlieg	2021	6
5	Bias in animal studies of estrogen effects on cardiovascular disease: A systematic review and meta‐analysis Research and Practice in Thrombosis and Haemostasis ·Christopher Friis Berntsen,Pernille Rootwelt,Anders Erik Astrup Dahm	2021	3
6	Safety of D‐dimer testing as a stand‐alone test for the exclusion of deep vein thrombosis as compared with other strategies Journal of Thrombosis and Haemostasis ·Synne G. Fronas,Hilde Skuterud Wik,Anders Erik Astrup Dahm,Camilla Tøvik Jørgensen,Jostein Gleditsch,Nezar Raouf,Frederikus A. Klok,Waleed Ghanima	2018	22
7	Rivaroxaban Versus Warfarin for the Prevention of Post-Thrombotic Syndrome Journal of Vascular Surgery Venous and Lymphatic Disorders ·Kristin Kornelia Utne,Anders Erik Astrup Dahm,Hilde Skuterud Wik,Lars‐Petter Jelsness‐Jørgensen,Per Morten Sandset,Waleed Ghanima	2018	0
8	Relationship between sex hormone binding globulin and blood coagulation in women on postmenopausal hormone treatment Blood Coagulation & Fibrinolysis ·Anette Løken Eilertsen,Anders Erik Astrup Dahm,Else Høibraaten,Cathrine M. Lofthus,Marie‐Christine Mowinckel,Per Morten Sandset	2018	8
9	Rivaroxaban versus warfarin for the prevention of post-thrombotic syndrome Thrombosis Research ·Kristin Kornelia Utne,Anders Erik Astrup Dahm,Hilde Skuterud Wik,Lars‐Petter Jelsness‐Jørgensen,Per Morten Sandset,Waleed Ghanima	2018	36
10	Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial PLoS ONE ·Christian Prebensen,Marius Trøseid,Thor Ueland,Anders Erik Astrup Dahm,Per Morten Sandset,Ingeborg S. Aaberge,K. Waalen,Anne Ma Dyrhol‐Riise,Kjetil Taskén,Dag Kvale	2017	8
11	A novel hypoxia response element regulates oxygen-related repression of tissue factor pathway inhibitor in the breast cancer cell line MCF-7 Thrombosis Research ·Xue Cui,Grethe Skretting,Mari Tinholt,Benedicte Stavik,Anders Erik Astrup Dahm,Kristine Kleivi Sahlberg,Sandip M. Kanse,Nina Iversen,Per Morten Sandset	2017	18
12	Effect of hypoxia on tissue factor pathway inhibitor expression in breast cancer Journal of Thrombosis and Haemostasis ·Xue Cui,Mari Tinholt,Benedicte Stavik,Anders Erik Astrup Dahm,Sandip M. Kanse,Yongmei M. Jin,Sebastian Seidl,Kristine Kleivi Sahlberg,Nina Iversen,Grethe Skretting,Per Morten Sandset	2015	20
13	Adaptation of Trustworthy Guidelines Developed Using the GRADE Methodology CHEST Journal ·Annette Kristiansen,Linn Brandt,Thomas Agoritsas,Elie A. Akl,Eivind Berge,Johan Bondi,Anders Erik Astrup Dahm,Lars‐Petter Granan,Sigrun Halvorsen,Pål-Andre Holme,Anne Flem Jacobsen,Eva‐Marie Jacobsen,Ignacio Neumann,Per Morten Sandset,T. Sætre,Arnljot Tveit,Trond Vartdal,Gordon Guyatt,Per Olav Vandvik	2014	16
14	A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women Thrombosis Research ·Anders Erik Astrup Dahm,Anette Løken Eilertsen,Jelle J. Goeman,Ole Kristoffer Olstad,Reidun Øvstebø,Peter Kierulf,Marie‐Christine Mowinckel,Grethe Skretting,Per Morten Sandset	2012	10
15	Differential haemostatic risk factors for pregnancy-related deep-vein thrombosis and pulmonary embolism Thrombosis and Haemostasis ·Anders Erik Astrup Dahm,Anne Flem Jacobsen,Leiv Sandvik,Per Morten Sandset,Astrid Bergrem	2012	14
16	An Exploratory Trial of Cyclooxygenase Type 2 Inhibitor in HIV-1 Infection: Downregulated Immune Activation and Improved T Cell-Dependent Vaccine Responses Journal of Virology ·Frank Olav Pettersen,Eirik A. Torheim,Anders Erik Astrup Dahm,Ingeborg S. Aaberge,Andreas Lind,Malin Holm,Einar Martin Aandahl,Per Morten Sandset,Kjetil Taskén,Dag Kvale	2011	53
17	Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor Journal of Thrombosis and Haemostasis ·Hubertus A.A.M. van Vliet,R M Bertina,Anders Erik Astrup Dahm,Frits R. Rosendaal,Jan Rosing,Per Morten Sandset,Frans M. Helmerhorst	2008	60
18	The association between protein S levels and anticoagulant activity of tissue factor pathway inhibitor type 1 Journal of Thrombosis and Haemostasis ·Anders Erik Astrup Dahm,Per Morten Sandset,Frits R. Rosendaal	2008	21
19	Tissue factor pathway inhibitor anticoagulant activity: risk for venous thrombosis and effect of hormonal state British Journal of Haematology ·Anders Erik Astrup Dahm,Frits R. Rosendaal,Trine Opstad Andersen,Per Morten Sandset	2005	10
20	Angiogenesis and Hemostasis in Hematological Neoplasias Current Drug Targets ·Helene F. S. Negaard,Anders Erik Astrup Dahm,Per Morten Sandset,Per Ole Iversen,Bj∅rn Østenstad	2005	4

About Anders Erik Astrup Dahm

Anders Erik Astrup Dahm is a scholar working on Internal Medicine, Hematology and Genetics, having authored 56 papers that have together received 1.1k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (29 papers), Blood Coagulation and Thrombosis Mechanisms (20 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (12 papers), Atrial Fibrillation Management and Outcomes (7 papers), Hemophilia Treatment and Research (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Estrogen and related hormone effects (4 papers) and Acute Ischemic Stroke Management (4 papers). The work is most often cited by research in Internal Medicine (388 citations), Hematology (531 citations) and Genetics (177 citations). Anders Erik Astrup Dahm has collaborated with scholars based in Norway, Netherlands and United States. Frequent co-authors include Per Morten Sandset, Frits R. Rosendaal, Astrid van Hylckama Vlieg, Rogier M. Bertina, Bjørn Bendz, Jan Rosing, Anne Flem Jacobsen, R M Bertina, Frans M. Helmerhorst and Hubertus A.A.M. van Vliet. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact